The Best Stocks to Invest $1,000 in Right Now

Are you looking to invest $1,000 in growth stocks? You can consider The Trade Desk stock and Well Health stock right now.

| More on:

Bear markets provide investors an opportunity to create generational wealth, as the valuations of most growth stocks move lower at an accelerated pace during periods of turmoil. If you can successfully identify quality stocks trading at a discount, you can build significant wealth over time, even with a small amount of capital.

For example, an investment of $1,000 in Amazon stock at the depths of the dot-com bubble would be worth close to $265,000 today. So, let’s see where you can invest $1,000 right now.

The Trade Desk stock

A company that operates in the programmatic advertising space, The Trade Desk (NASDAQ:TTD) is valued at a market cap of $27.4 billion. Down 50% from all-time highs, TTD stock should be on your watchlist in March 2023.

Despite a weak macro environment and lower enterprise ad spending, The Trade Desk increased its sales by 24% year over year to US$491 million in the fourth quarter (Q4) of 2022.

The company is well poised to benefit from the global shift towards online streaming, as the connected TV segment is a major business for TTD. Ad spending in the Connected TV vertical is forecast to double in the next four years, making TTD a solid bet right now.

In the last three years, The Trade Desk has already increased revenue from US$661 million in 2019 to US$1.58 billion in 2022. Analysts now expect sales to touch US$2.4 billion in 2024.

So, TTD stock is priced at 11 times forward sales, which is quite steep. But Wall Street remains bullish on the tech stock and expects it to surge over 20% in the next year.

Right now, sales generated outside North American markets account for just 10% of total revenue. But ad sales in global markets (excluding North America) account for 67% of total sales, providing enough room for TTD to drive the top line higher.

Well Health stock

A digital-health company, Well Health (TSX:WELL) has already returned a monstrous 4,460% to investors since its initial public offering seven years back. Now valued at a market cap of $1.04 billion, Well Health stock is also down 50% from record highs.

Well Health aims to provide a robust end-to-end healthcare system in Canada while offering omni-channel healthcare services and solutions in specialized markets in the U.S.

It expects to end 2022 with revenue of $565 million, adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) of $100 million, and a free cash flow of $50 million. So, WELL stock is priced at 20 times trailing free cash flow, which is quite reasonable for a growth stock.

Around 90% of its sales are recurring in nature, which should enable Well Health to report consistent cash flows across business cycles.

In the last few years, Well Health has depended on highly accretive acquisitions, in addition to organic growth, to increase sales. It acquired a 58% stake in Circle Medical for US$14 million in November 2020, and this entity has increased sales by a whopping 1,000% in the last two years. Well Health also acquired CRH Medical for US$373 million, which increased profitability by 17% in the last 12 months.

At current prices, Well Health stock is trading at a discount of 70% to consensus price target estimates.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Trade Desk. The Motley Fool recommends Amazon.com. The Motley Fool has a disclosure policy.

More on Tech Stocks

think thought consider
Tech Stocks

Is CGI Stock a Buy Even With No Dividend Yield?

CGI stock may not have a dividend to speak of. But does that necessarily mean you should ignore this top…

Read more »

A robotic hand interacting with a visual AI touchscreen display.
Tech Stocks

Why Now Is the Time to Invest in Canadian AI Stocks

Are you looking for one of the most solid Canadian AI stocks out there? This one is probably your best…

Read more »

The letters AI glowing on a circuit board processor.
Tech Stocks

Why AI Stocks Should Be in Every Canadian Investor’s Portfolio

AI stocks continue to be one of the best options out there for long-term investing, especially when considering Canadian options.

Read more »

money goes up and down in balance
Tech Stocks

1 “Magnificent 7” Stock I’d Buy Over Nvidia Right Now

Here's why Meta Platforms stock is a better choice for Canadian investors compared to Nvidia in November 2024.

Read more »

A data center engineer works on a laptop at a server farm.
Tech Stocks

3 No-Brainer Data Centre Stocks to Buy With $500 Right Now

Data centres are going to be a huge growth opportunity in the next decade. And these are the top buys.

Read more »

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Is OpenText Stock a Buy, Sell, or Hold for 2025?

OpenText stock has fallen in the last few years, but that could mean this top tech stock remains an undervalued…

Read more »

AI microchip
Tech Stocks

Celestica Stock: Buy, Sell, or Hold?

Celestica's stock price has rallied 950% in the last five years. Will the AI boom send it even higher in…

Read more »

data analyze research
Tech Stocks

2 Ridiculously Cheap Growth Stocks to Buy Hand Over Fist in 2024

Well Health Technologies is a cheap growth stock to buy for its record-breaking results, massive revenue growth, and profitability.

Read more »